1. Repository of OAI
  2. ΑΠΟΘΕΤΗΡΙΟ "ΟΛΥΜΠΙΑΣ"
  3. Σχολή Επιστημών Υγείας
  4. Τμήμα Ιατρικής
  5. Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ
Ελληνικά   English  
Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22991
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPapageorgiou, E. S.en
dc.contributor.authorTsirigotis, P.en
dc.contributor.authorDimopoulos, M.en
dc.contributor.authorPavlidis, N.en
dc.contributor.authorFountzilas, G.en
dc.contributor.authorPapageorgiou, S.en
dc.contributor.authorEconomopoulos, T.en
dc.date.accessioned2015-11-24T19:29:42Z-
dc.date.available2015-11-24T19:29:42Z-
dc.identifier.issn0902-4441-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22991-
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectAntineoplastic Combined Chemotherapy Protocols/*administration & dosage/toxicityen
dc.subjectDeoxycytidine/administration & dosage/*analogs & derivativesen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectLymphoma, B-Cell/drug therapyen
dc.subjectLymphoma, Large B-Cell, Diffuse/*drug therapyen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectRemission Inductionen
dc.subjectSalvage Therapy/*methodsen
dc.subjectSurvival Analysisen
dc.subjectVinblastine/administration & dosage/*analogs & derivativesen
dc.titleCombination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Groupen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1111/j.1600-0609.2005.00482.x-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/16000128-
heal.identifier.secondaryhttp://onlinelibrary.wiley.com/store/10.1111/j.1600-0609.2005.00482.x/asset/j.1600-0609.2005.00482.x.pdf?v=1&t=h0nicf9w&s=195eee210035d7b43f39aea1cc3603a3bec9bacb-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2005-
heal.abstractTo investigate the efficacy and toxicity of the combination of gemcitabine and vinorelbine in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBL), 22 patients with relapsed or refractory DLBL were treated with gemcitabine 1000 mg/m2 and vinorelbine 30 mg/m2 on days 1 and 8 every 3 wk for a maximum of six cycles. Fourteen patients were considered chemosensitive while eight patients were considered chemoresistant to the last treatment regimen. All 22 patients were assessed for response to treatment. Three patients (14%) achieved complete remission and eight patients (36%) had partial remission of their disease, with an overall response rate of 50%. With a median follow up of 44 months, the median time to progression (TTP) for all patients was 8.1 months while the median overall survival (OS) was 12.9 months. Toxicity was minimal and all patients were treated on an outpatient basis. The combination of gemcitabine and vinorelbine is an effective and well-tolerated regimen for patients with relapsed of refractory DLBL.en
heal.journalNameEur J Haematolen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Show simple item record
Files in This Item:
File Description SizeFormat 
Papageorgiou-2005-Combination chemothe.pdf109.99 kBAdobe PDFView/Open    Request a copy
Show simple item record  


This item is licensed under a Creative Commons License Creative Commons